Pfizer To Phase Out Manufacturing at Groton
Pfizer, Inc. (New York, NY) will phase out manufacturing operations in Groton, Connecticut, eliminating roughly 300 jobs.
Pfizer, Inc. (New York, NY, www.pfizer.com) will phase out manufacturingoperations in Groton, Connecticut, eliminating roughly 300 jobs.
The move would allow the company to expand its research and developmentoperations in Groton near the 50-acre manufacturing site. Pfizer'sGroton and New London sites in Connecticut are the company's largestresearch sites, employing roughly 6000 people.
The move is part of Pfizer's company-wide restructuring effort,announced in 2005, under which Pfizer hopes to save $4 billion annuallyby 2008.
Pfizer plans to begin cutting its Groton manufacturing operations in2007. The facility makes active ingredients for several pharmaceuticalsand animal health products, and the company plans to transfer the manufacture of those products to other plants.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
